News | May 23, 2011

Treatment Planning Software Maker Sues Over Alleged Patent Infringement

May 23, 2011 - Radiation Therapy treatment planning system developers RaySearch Laboratories AB and Prowess Inc. are involved in patent infringmenrt litigation. Prowess recently filed a complaint against RaySearch for U.S. patent infringement in a court in Baltimore, Md.

RaySearch said the two companies had been in discussions over the issue, but they were fruitless and Prowess moved ahead with the litigation.

The patent concerns direct optimization of machine parameters in radiation treatment planning and was issued in 2007 by the U.S. patent authority USPTO. Prowess has said that it holds an exclusive license to this patent, which is owned by the University of Maryland. RaySearch has been involved in discussions with Prowess where RaySearch has stated its position that there is no infringement and in addition, that the patent could be invalidated since there is prior art in older publications describing the same concept.

“This concerns a method that we had independently developed and implemented at the Karolinska Institute already in the ‘90s. In addition, both we and others had published articles about the method before this patent application was filed. We do believe that we have a strong case and therefore consider our chances of winning this dispute to be good,” said Johan Löf, CEO of RaySearch.

Prowess Inc. is an international radiation cancer treatment planning software developer, using Windows-based systems.

RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are mainly sold through license agreements with leading partners such as Philips, Nucletron, IBA Dosimetry, Varian, TomoTherapy and Siemens. To date, 15 products have been launched through partners and RaySearch’s software is used at some 1,800 clinics in more than 30 countries.

For more information: www.raysearchlabs.com, www.prowess.com

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more